FISM
Exploring pathogenic mechanisms associated with depression in multiple sclerosis: functional and structural disconnectivity of neurotransmitter-related nuclei
Lender: FISM
Horizon 2020 - 3TR
Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions
Lender: European Union
CogEx
A Multi-Arm, Randomizeda, Blinded, Sham-Controlled Trial of Cognitive Rehabilitation and Aerobic Exercise
Lender: MS Foundation
R01 NS099527
Examining the role of brain sodium content in MS using MRI
Lender: NINDS/NIH
R01 NS100811
MRI predictors of disease and disability progression in African-Americans with MS
Lender: NINDS/NIH
RG 4916A2/1
A 7 Tesla MRI post-mortem study of gray matter lesions in MS
Lender: National MS Society
RG 5120A3/1
Multimodal longitudinal Imaging in progressive MS
Lender: National MS Society
Roche
Monitoring grey matter damage and retinal thickness in MS patients: the combined role of MRI and OCT
Lender: ROCHE Research Agreement
RIN
Rete di Neuroimaging avanzato - Fase IV: laboratorio virtuale di neuroimmagini verso una medicina personalizzata/di precisione
Lender: Ministero della Salute
5x1000
"Ageing" e sclerosi multipla: studio dell'immunosenescenza e dei correlati MRI
Lender: Ministero della salute (5x1000)
Horizon 2020 - REMAp
Adaptive and personalized neuromotor rehabilitation of persons with Multiple Sclerosis: from characterization to exploration of residual sensorimotor abilities using a body- machine interface
Lender: Unione europea
INAIL
The rehabilitative approach as a qualifying factor in the reasonable accommodation of workers with multiple sclerosis.
Ente finanziatore: INAIL
REPAIR FIS_00002258
Tissue recovery and plasticity after CNS inflammatory demyelinating relapses
Ente finanziatore: FIS
2023-2028
Functionally and Anatomically Informed Tractography of the Human brain (FAITH)
Ente finanziatore: PRIN (PROGETTI DI RICERCA DI RILEVANZA NAZIONALE)
2022-2024
Advancing MRI biomarkers of brain tissue microstructure and energetics in Multiple Sclerosis
Ente finanziatore: PRIN (PROGETTI DI RICERCA DI RILEVANZA NAZIONALE)
2022-2024